TW202404991A - 大環肽抗生素之結晶形式 - Google Patents

大環肽抗生素之結晶形式 Download PDF

Info

Publication number
TW202404991A
TW202404991A TW112112829A TW112112829A TW202404991A TW 202404991 A TW202404991 A TW 202404991A TW 112112829 A TW112112829 A TW 112112829A TW 112112829 A TW112112829 A TW 112112829A TW 202404991 A TW202404991 A TW 202404991A
Authority
TW
Taiwan
Prior art keywords
atr
xrpd
approximately
pattern
crystalline
Prior art date
Application number
TW112112829A
Other languages
English (en)
Chinese (zh)
Inventor
勞夫 杜當
安德列 艾格里
丹尼斯 迪莫 安可曼
米歇爾 多米尼克 林德摩爾
瓦倫汀 安德列亞斯 史戴德爾曼
Original Assignee
瑞士商赫孚孟拉羅股份公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 瑞士商赫孚孟拉羅股份公司 filed Critical 瑞士商赫孚孟拉羅股份公司
Publication of TW202404991A publication Critical patent/TW202404991A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0815—Tripeptides with the first amino acid being basic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
TW112112829A 2022-04-07 2023-04-06 大環肽抗生素之結晶形式 TW202404991A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP22167057.3 2022-04-07
EP22167057 2022-04-07

Publications (1)

Publication Number Publication Date
TW202404991A true TW202404991A (zh) 2024-02-01

Family

ID=81448543

Family Applications (1)

Application Number Title Priority Date Filing Date
TW112112829A TW202404991A (zh) 2022-04-07 2023-04-06 大環肽抗生素之結晶形式

Country Status (10)

Country Link
EP (1) EP4504749A1 (enExample)
JP (1) JP2025511869A (enExample)
KR (1) KR20240169690A (enExample)
CN (1) CN118974073A (enExample)
AU (1) AU2023250008A1 (enExample)
CA (1) CA3255726A1 (enExample)
IL (1) IL315686A (enExample)
MX (1) MX2024012228A (enExample)
TW (1) TW202404991A (enExample)
WO (1) WO2023194418A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2026154152A1 (en) * 2025-01-20 2026-07-23 F. Hoffmann-La Roche Ag Pharmaceutical compositions comprising an antibiotic macrocyclic peptide

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11819532B2 (en) 2018-04-23 2023-11-21 Hoffmann-La Roche Inc. Peptide macrocycles against Acinetobacter baumannii

Also Published As

Publication number Publication date
CN118974073A (zh) 2024-11-15
CA3255726A1 (en) 2023-10-12
EP4504749A1 (en) 2025-02-12
IL315686A (en) 2024-11-01
MX2024012228A (es) 2024-11-08
WO2023194418A1 (en) 2023-10-12
KR20240169690A (ko) 2024-12-03
AU2023250008A1 (en) 2024-10-03
JP2025511869A (ja) 2025-04-16

Similar Documents

Publication Publication Date Title
EP3946364B1 (en) Solid forms of an orally-delivered beta-lactamase inhibitor and uses thereof
JP5701246B2 (ja) 有機化合物
EP2753613B1 (en) Derivatives of xanthone compounds
TW200533340A (en) Rifamycin analogs and uses thereof
CN107056813B (zh) 德罗格韦钠盐的晶型及其制备方法
JP5152527B2 (ja) ペネムプロドラッグ
JP7843116B2 (ja) ２－（５－（４－（２－モルホリノエトキシ）フェニル）ピリジン－２－イル）－ｎ－ベンジルアセトアミドの固体形態
KR20240169690A (ko) 거대고리 펩티드 항생제의 결정질 형태
CN101180300A (zh) 用作抗感染剂的新的异噻唑喹诺酮及相关化合物
CN107427507B (zh) 呼吸器官感染治疗剂
HK40114674A (en) Crystalline forms of a macrocyclic peptide antibiotic
CN114466652A (zh) (r)-2-[2-氨基-3-(吲哚-3-基)丙酰基氨基]-2-甲基丙酸的新型多晶型物晶型及其用途
CZ217694A3 (en) 3/2 hydrate and anhydrate of 7-/(7-(s)-amino-5-azaspiro/2.4/heptan-5-yl/-8-chloro-6-fluoro-1-/(1r,2s) 2-fluorocyclopropyl/-4-oxo-1,4-dihydroquinoline-3-carboxylic acid, processes of selective production of 3/2 hydrate, crystals thereof and antibacterial agents based thereon
TW202409022A (zh) ６－（（５－甲基－３－（６－甲基吡啶－３－基）異唑－４－基）甲氧基）－ｎ－（四氫哌喃－４－基）嗒𠯤－３－甲醯胺之結晶形式
JP2014503578A (ja) Ｍｄｒポンプ阻害活性を有する新規なアザクマリン誘導体
CZ53299A3 (cs) Polycyklické deriváty ftalazinu, jejich použití a léčiva tyto látky obsahující